Close Menu

Genedata

The multi-omics translational software developer is helping the Crohn's & Colitis Foundation validate its research into biomarkers that can predict complications requiring surgery.

Bruker signed a codevelopment and comarketing agreement with PreOmics for sample prep, and a partnership with Genedata for proteomics software.

The Epigenetics For Female Personalised Cancer Care (EpiFemCare) project recently published its findings in two papers in the journal Genome Medicine.

The partners will integrate Genedata's analytics with IntelliCyt's high-throughput flow-cytometry screening system to enable efficient screens of drug candidates.

NEW YORK (GenomeWeb News) — Genedata announced today that Takara Bio has chosen the Genedata Expressionist software platform for use in all its genomics, transcriptomics, and epigenomics research.

NEW YORK (GenomeWeb) – Genedata said this week that the FUNGITECT consortium has tapped its Genedata Selector platform to analyze both host and pathogen sequence data in its projects.

NEW YORK (GenomeWeb) – Genedata said this week that GlaxoSmithKline's biopharma research and development arm has selected its Genedata Biologics software to handle data management and workflow support needs.

NEW YORK (GenomeWeb) – Genedata said this week that it has integrated its Genedata Analyst software with the TranSMART platform, an open-source knowledge-management platform managed by the TranSMART Foundation that lets users integrate phenotype data and molecular information in translational res

Genedata said this week that the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP)in Stuttgart, Germany has licensed the Genedata Expressionist software for use in its pharmacogenomics and oncology translational research projects.

Genedata has released a new version of Genedata Expressionist for Mass Spectrometry, its software for the analyzing metabolomics data.
Version 8.0 includes new workflows for integrated processing of LC- and GC-MS data.

Pages

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.